Richard Segal, R.Ph., Ph.D., M.S.
Professor
Department:
Pharmaceutical Outcomes & Policy
Business Phone:
(352) 273-6265
Business Email:
segal@ufl.edu
About Richard Segal
Richard Segal, Ph.D., is a professor of Pharmaceutical Outcomes & Policy at the University of Florida College of Pharmacy and also holds a faculty appointment in the Department of Pharmacotherapy and Translational Research. His research interests focuses on improving the quality and safety of the medication use process, with a particular emphasis on improving prescribing practices and in creating collaborative practice models to improve medication use by patients.
Segal is widely recognized for his work in explaining why clinical practice is so often inconsistent with evidence-based best practices. His research in the area of changing prescribing behavior has been the basis of prescribing interventions throughout the world. Segal was Co-PI on the first major research project focused on training community pharmacists to identify and prevent drug related problems which contribute to preventable drug related morbidity called Therapeutic Outcomes Monitoring (TOM). Their research has helped to shape many medication therapy management interventions used by health plans in the United States and in other countries.
Accomplishments
Faculty Teaching Excellence Award
2024
·
University of Florida
Team Teaching Award – First Place
2024
·
University of Florida
Paul Doering Excellence in Teaching Professor Award
2021
·
University of Florida
Teacher of the Year
2021
·
College of Pharmacy
APhA-APPM Presentation Merit Award Finalist
2020
·
American Pharmacists Association
Silver Award for Best Research Paper
2018
·
American Managed Care Pharmacy
Outstanding Team Teaching Award, Course Coordinator
2017
·
University of Florida
Silver Awards for Best Research Paper
2016
·
Amiercan Managed Care Pharmacy
Gold Award for Best Research Paper
2015
·
American Managed Care Pharmacy
Honorable Mention for Best Research Presentation
2013
·
American Managed Care Pharmacy
Dr. Robert and Dr. Robert and Barbara Crisafi Endowed Chair in Pharmaceutical Outcomes and Policy
2011-2016
·
Univesity of Florida
APHA-APRS 'Postgraduate Best Paper Award' in the Clinical Sciences section
2004
·
American Pharmacists Association
"Best of Blue" National Research Award
2001
·
Blue Cross Blue Shield
NACDS Research Award for Faculty Mentor
2001
·
NACDS
University of Florida Research Foundation Professor
1999-2001
·
University of Florida
Best Published Paper Award
1999
·
American Pharmaceutical Association
Award for Practice Research
1997
·
American Society of Health-Systems Pharmacy
Searle Fellowship in Pharmacy – Second Place Award to Faculty Mentor
1996
·
Searle
Searle Fellowship in Pharmacy – First Place Award to Faculty Mentor
1995
·
Searle
Glaxo Pharmacoeconomics Award
1994
·
Glaxo
Smith Kline & French Research Award for Hospital Pharmacy Practice i
1989
·
Smith Kline & French
Smith Kline & French Tagamet Investigator's Award
1988
·
Smith Kline & French
Upjohn Award for Research in Clinical Pharmacy
1988
·
Upjohn
Central Ohio Society of Hospital Pharmacists Research Award
1987
·
Central Ohio Society of Hospital Pharmacists
Central Ohio Society of Hospital Pharmacists Research Award
1985
·
Central Ohio Society of Hospital Pharmacists
Teaching Profile
Courses Taught
2009-2022
PHA7979 Advanced Research
2009-2023
PHA6910 Supervised Research
2010-2012,2017-2022,2020-2022
PHA6971 Research for Master’s Thesis
2009-2018,2020-2022
PHA7980 Research for Doctoral Dissertation
2009-2016,2020-2024
PHA6935 Selected Topics in Pharmacy
2019-2024
PHA7939 Journal Club in Pharmaceutical Sciences
2015-2024
PHA5103 Prin Pt Centered Care
2010-2013,2016-2024
PHA6228 Institutional Pharmacy Leadership II
2010-2013,2015-2022
PHA6227 Institutional Pharmacy Leadership I
2010-2024
PHA6937 Topics in Pharmaceutical Administration
2010-2012,2015-2020,2018-2024
PHA6265 Introduction to Pharmaceutical Outcomes and Policy I
2011,2019-2021
PHA6940 Supervised Teaching
2010-2024
PHA6936 Advanced Topics in Pharmaceutical Sciences
2018
PHA5878C Pt Care 3: Cv and Pulm
2009-2015,2017
PHA6266 Introduction to Pharmaceutical Outcomes and Policy II
2014-2016
PHA5742C Pro Commun Pharm Prac
2015
PHA5007 Pharm and Pop Health
2010-2015
PHA6279 Pharmaceutical Outcomes and Policy Seminar
2009-2011,2013-2015
PHA5901 Res Ph Outcome and Plcy
2014-2015
PHA5270 Health Care and Patient Safety
2015
PHA5271 Health Care Risk Management
2012-2014
PHA6291 Pharmaceutical Health Care Systems
2007,2014-2021,2021-2023,2023
PHA6938 Research Seminar
2010,2013-2014
PHA6805 Applied Data Interpretation and Reporting of Findings in Pharmacy
2013
PHA5267 Crit Appr Pharmacoeco
2009-2010
PHA4901 Probs Pharm Outcome
2010
PHA6274 Federal Regulations of Drugs and Pharmacy
2009
PHA6287 Pharmaceutical Health Economics
2008
PHA6717 Measurement in Pharmacy Administration Research
2021
PHA6894 Introduction to Graduate Studies
2021-2024
PHA7900 Journal Club in Pharmaceutical Research
2022-2024
PHA5244 Prin Evid Based Prac
Board Certifications
-
PGY-1 ResidencyMayo Clinic, Saint Mary's Hospital – Rochester MN
Research Profile
Dr. Segal’s research focuses on improving the quality and safety of the medication use process, with a particular emphasis on improving prescribing practices and in creating collaborative practice models to improve medication use by patients.
Open Researcher and Contributor ID (ORCID)
0000-0002-7253-8227
Publications
2024
Medication Adherence Associated with Better Cardiometabolic Control among American Indians with Type 2 Diabetes
Diabetes.
73
2024
Medication Engagement, Determinants of Health, and A1C Levels Among Adults With Type 2 Diabetes within a Tribal Health System.
The science of diabetes self-management and care.
50(4):275-286
[DOI] 10.1177/26350106241259007.
[PMID] 39082085.
2023
Association of Medication Adherence With HbA1c Control Among American Indian Adults With Type 2 Diabetes Using Tribal Health Services.
Diabetes care.
46(6):1245-1251
[DOI] 10.2337/dc22-1885.
[PMID] 37068266.
2023
Clinician barriers, perceptions, and practices in treating patients with hepatitis C virus and substance use disorder in the United States.
Preventive medicine reports.
32
[DOI] 10.1016/j.pmedr.2023.102138.
[PMID] 36865395.
2023
Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center: Structure, Innovations, and Initial Outcomes.
Cancer control : journal of the Moffitt Cancer Center.
30
[DOI] 10.1177/10732748231197878.
[PMID] 37703814.
2022
Comparative Safety of Sleeve Gastrectomy and Roux-en-Y: A Propensity Score Analysis.
World journal of surgery.
46(11):2715-2724
[DOI] 10.1007/s00268-022-06664-0.
[PMID] 35840690.
2022
Medication Adherence and Cardiometabolic Control Indicators Among American Indian Adults Receiving Tribal Health Services: Protocol for a Longitudinal Electronic Health Records Study
JMIR Research Protocols.
11(10)
[DOI] 10.2196/39193.
[PMID] 36279173.
2021
Clinical Conditions and Prescription Drug Utilization among Early Medical Marijuana Registrants in Florida
Journal of Psychoactive Drugs.
53(3):185-194
[DOI] 10.1080/02791072.2020.1864069.
2021
Non-steroidal anti-inflammatory drug-associated acute kidney injury: does short-term NSAID use pose a risk in hospitalized patients?
European journal of clinical pharmacology.
77(9):1409-1417
[DOI] 10.1007/s00228-021-03121-0.
[PMID] 33772627.
2021
US national trends in bariatric surgery: A decade of study
Surgery.
170(1):13-17
[DOI] 10.1016/j.surg.2021.02.002.
2020
Characteristics of Older Adults Who Were Early Adopters of Medical Cannabis in the Florida Medical Marijuana Use Registry.
Journal of clinical medicine.
9(4)
[DOI] 10.3390/jcm9041166.
[PMID] 32325769.
2020
Missed opportunities for pneumococcal vaccinations in high-risk and older adults in the United States.
Journal of infection and public health.
13(1):101-103
[DOI] 10.1016/j.jiph.2019.06.010.
[PMID] 31279802.
2020
Opportunities and responsibilities for pharmacists to improve their effectiveness in addressing medication adherence through culturally sensitive collaborations with community health workers.
Journal of the American Pharmacists Association : JAPhA.
60(4):e25-e30
[DOI] 10.1016/j.japh.2020.02.023.
[PMID] 32217086.
2020
Prevalence of substance use disorder and psychiatric comorbidity burden among pregnant women with opioid use disorder in a large administrative database, 2009-2014.
Journal of psychosomatic obstetrics and gynaecology.
1-7
[DOI] 10.1080/0167482X.2020.1727882.
[PMID] 32067526.
2020
Socioeconomic and Demographic Characteristics of US Adults Who Purchase Prescription Drugs From Other Countries.
JAMA network open.
3(6)
[DOI] 10.1001/jamanetworkopen.2020.8968.
[PMID] 32579194.
2020
The Pharmacist as an LGBTQ Ally.
American journal of pharmaceutical education.
84(7)
[DOI] 10.5688/ajpe7835.
[PMID] 32773835.
2020
Using a pharmacist–community health worker collaboration to address medication adherence barriers
Journal of the American Pharmacists Association.
60(6):1009-1014
[DOI] 10.1016/j.japh.2020.08.021.
2019
Comparative Effectiveness and Safety of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome: A Retrospective Cohort Analysis.
Pharmacotherapy.
39(9):912-920
[DOI] 10.1002/phar.2311.
[PMID] 31332815.
2019
Impacting Student Self-Efficacy and Beliefs of Medication Therapy Management Through a Two-Week Elective.
American journal of pharmaceutical education.
83(5)
[DOI] 10.5688/ajpe6995.
[PMID] 31333264.
2019
Validation of mother-infant linkage using Medicaid Case ID variable within the Medicaid Analytic eXtract (MAX) database.
Pharmacoepidemiology and drug safety.
28(9):1222-1230
[DOI] 10.1002/pds.4843.
[PMID] 31286606.
2018
Association Between Recombinant Human Bone Morphogenetic Proteins and Postoperative Opioid Use in Lumbar Fusion Procedure Patients: A Propensity Score-Matched Analysis.
World neurosurgery.
120:e42-e52
[DOI] 10.1016/j.wneu.2018.07.125.
[PMID] 30170146.
2018
Risk of sudden sensorineural hearing loss in adults using phosphodiesterase type 5 inhibitors: Population-based cohort study.
Pharmacoepidemiology and drug safety.
27(6):587-595
[DOI] 10.1002/pds.4405.
[PMID] 29512263.
2018
Stimulants Do Not Increase the Risk of Seizure-Related Hospitalizations in Children with Epilepsy.
Journal of child and adolescent psychopharmacology.
28(2):111-116
[DOI] 10.1089/cap.2017.0110.
[PMID] 29028437.
2018
Trends in Readmission Rates, Hospital Charges, and Mortality for Patients With Chronic Obstructive Pulmonary Disease (COPD) in Florida From 2009 to 2014.
Clinical therapeutics.
40(4):613-626.e1
[DOI] 10.1016/j.clinthera.2018.03.006.
[PMID] 29609879.
2017
Combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model.
BMC pregnancy and childbirth.
17(1)
[DOI] 10.1186/s12884-016-1190-7.
[PMID] 28061833.
2017
Duration of Reproductive Years and the Risk of Cardiovascular and Cerebrovascular Events in Older Women: Insights from the National Health and Nutrition Examination Survey.
Journal of women's health (2002).
26(10):1047-1052
[DOI] 10.1089/jwh.2016.6013.
[PMID] 28525295.
2017
Identifying and characterizing preventable adverse drug events for prioritizing pharmacist intervention in hospitals.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
74(21):1774-1783
[DOI] 10.2146/ajhp160387.
[PMID] 29070499.
2017
Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.
Journal of managed care & specialty pharmacy.
23(1):13-21
[DOI] 10.18553/jmcp.2017.23.1.13.
[PMID] 28025924.
2017
Risk prediction model for in-hospital mortality in women with ST-elevation myocardial infarction: A machine learning approach.
Heart & lung : the journal of critical care.
46(6):405-411
[DOI] 10.1016/j.hrtlng.2017.09.003.
[PMID] 28992993.
2017
Trends in Antiepileptic Drug Use in Children and Adolescents With Epilepsy.
Pediatric neurology.
74:32-40
[DOI] 10.1016/j.pediatrneurol.2017.05.016.
[PMID] 28676250.
2016
Program evaluation. Handbook for Prostate Cancer Advocacy: Principles & Best Practices.
CaPTC.
2016
Risk of Suicidal Events With Atomoxetine Compared to Stimulant Treatment: A Cohort Study.
Pediatrics.
137(5)
[DOI] 10.1542/peds.2015-3199.
[PMID] 27244795.
2016
Stimulant use following the publicity of cardiovascular safety and the introduction of patient medication guides.
Pharmacoepidemiology and drug safety.
25(6):678-86
[DOI] 10.1002/pds.3894.
[PMID] 26597624.
2016
What explains the different rates of human papillomavirus vaccination among adolescent males and females in the United States?
Papillomavirus research (Amsterdam, Netherlands).
2:46-51
[DOI] 10.1016/j.pvr.2016.02.001.
[PMID] 29074185.
2015
Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
18(2):260-70
[DOI] 10.1016/j.jval.2014.11.007.
[PMID] 25773561.
2015
Discussion Between Providers and Patients About Prostate Specific Antigen Testing in Usa
Value in Health.
18(3)
2014
Comparison of Rates of Prescribing Oral Corticosteroids for Asthma Exacerbations Between Step-Down Therapy Approaches Among Initiators of Inhaled Corticosteroids and Long-Acting Beta-Agonist Combination Therapy
.
133(2, S)
2014
Epidemiology of Pre-Existing Diabetes in Pregnancy From 2000-2006 Among Medicaid Patients in 29 Us States
Pharmacoepidemiology and Drug Safety.
23(1, SI)
2014
Modern utilization of penile prosthesis surgery: a national claim registry analysis.
International journal of impotence research.
26(5):167-71
[DOI] 10.1038/ijir.2014.11.
[PMID] 24830674.
2014
Pharmacists’ perspective on providing care when patients engage in unhealthy behaviors.
Journal of the American Pharmacists Association : JAPhA.
54(2):159-62
[DOI] 10.1331/JAPhA.2014.13149.
[PMID] 24562598.
2014
Predicting Linkage Within a Validated Algorithm That Identifies Mother-Infant Pairs Within the Medicaid Analytic Extract (Max) Database
Pharmacoepidemiology and Drug Safety.
23(1, SI)
2014
Reliability and validity for the measurement of moral disengagement in pharmacists.
Research in social & administrative pharmacy : RSAP.
10(2):297-312
[DOI] 10.1016/j.sapharm.2013.06.006.
[PMID] 23891105.
2013
Long-Acting Beta-Agonists and Asthma Exacerbations Requiring Short Courses of Oral Corticosteroids: a Multi-Category Exposure Marginal Structural Models Analysis
Value in Health.
16
2013
Proceedings of the international workshop on cancer advocacy for african countries.
Infectious agents and cancer.
8 Suppl 1(Suppl 1)
[DOI] 10.1186/1750-9378-8-S1-S1.
[PMID] 23902950.
2013
The African cancer advocacy consortium: shaping the path for advocacy in Africa.
Infectious agents and cancer.
8 Suppl 1(Suppl 1)
[DOI] 10.1186/1750-9378-8-S1-S8.
[PMID] 23902674.
2011
Effects of Change in Price of Medical Care on Daily Living of People in the United States
Journal of Pharmaceutical Health Services Research.
2(3):205-210
2011
Proceedings of the 1st biennial science of global prostate cancer disparities in black men.
Infectious agents and cancer.
6 Suppl 2(Suppl 2)
[DOI] 10.1186/1750-9378-6-S2-I1.
[PMID] 21992588.
2010
Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice.
The Annals of pharmacotherapy.
44(1):88-96
[DOI] 10.1345/aph.1L289.
[PMID] 20040704.
2010
Investigation of the Potential Effects of Registration Requirements on Florida Pharmacy Technician Credentials
The Journal of Pharmacy Technology.
26:116-122
2010
Is antiepileptic drug use related to depression and suicidal ideation among patients with epilepsy?
Epilepsy & behavior : E&B.
19(3):494-500
[DOI] 10.1016/j.yebeh.2010.08.030.
[PMID] 20880757.
2009
Family caregiver quality of life: the impact of demands of caregiving, medication administration and stress in a pediatric oncology setting
Oncology Nursing Forum.
36(1)
2007
Constructs underlying community pharmacy dispensing functions relative to Florida pharmacy technicians.
Journal of the American Pharmacists Association : JAPhA.
47(5):588-98
[PMID] 17848348.
2007
Physicians’ intent to comply with the American Medical Association’s guidelines on gifts from the pharmaceutical industry.
Journal of medical ethics.
33(6):313-9
[PMID] 17526679.
2007
Projected Cost Savings Comparison to Managed Care organizations for the Year Following Generic Simvastatin and Pravastatin Availability in the U.S
Value in Health.
10(3):2-19
2006
The Economic Burden of End-Stage Renal Disease with Hyperphosphatemia: A Study of Florida Medicaid
Disease Management & Health Outcomes.
14(2):99-106
2005
A pharmacist model of perceived responsibility for drug therapy outcomes.
Social science & medicine (1982).
60(10):2393-403
[PMID] 15748686.
2004
An evaluation of enhancements in electronic technology for prescribers in Florida Medicaid program
Agency for Health Care Administration.
2004
Evaluation of Pharmacist Interventions in Diabetic Patients from Rural Community Health Centers
Value in Health.
7(3)
2004
Identification and treatment of Medicaid recipients with Hepatitis C
Agency for Health Care Administration.
2004
Impact of Point-of-care Information about Medications on Health Outcomes in Community Health Centers
Bureau of Primary Health Care.
2004
Predicting physician guideline compliance: an assessment of motivators and perceived barriers.
The American journal of managed care.
10(6):383-91
[PMID] 15209482.
2004
Resource use and cost of care for patients hospitalised with community acquired pneumonia: impact of adherence to infectious diseases society of america guidelines.
PharmacoEconomics.
22(11):751-7
[PMID] 15250752.
2004
The economic impact on glycemic control as measured by glycosylated hemoglobin- a systematic review of diabetes outcomes studies
Agency for Health Care Administration.
2003
A randomized trial of an acid-peptic disease management program in a managed care environment.
The American journal of managed care.
9(6):425-33
[PMID] 12816172.
2003
Cost-minimization analysis of a pharmacist-directed pantoprazole intravenous to oral dosage form conversion program
Value in Health.
6(3)
2003
Impact of an antidepressant management program on medication adherence.
The American journal of managed care.
9(1):70-80
[PMID] 12549816.
2003
Nature of preventable adverse drug events in hospitals: a literature review.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
60(17):1750-9
[PMID] 14503111.
2003
Preventing medication errors and improving drug therapy outcomes: A management systems approach
Boca Raton FL: CRC Press, .
[DOI] ISBN: 0-8493-1576-X..
2003
Reducing claims for prescription drugs with a high potential for abuse.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
60(4):371-4
[PMID] 12625220.
2002
Identifying clinically significant preventable adverse drug events through a hospital’s database of adverse drug reaction reports.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
59(18):1742-9
[PMID] 12298112.
2002
Pharmacoeconomic studies of asthma controller drugs: marketing gimmick or icing on the cake?
Pharmacotherapy.
22(2):131-3
[PMID] 11837550.
2001
Application of Pharmacoeconomics and Decision Analysis to Gastrointestinal Disorders Within a Broad-Based Disease Management Program
Introduction to Pharmacoeconomics. .
.). New York: McGraw Hill:144-178
2001
ASHP Therapeutic Position Statement on the recognition and treatment of Helicobacter pylori disease.
Am J Health-System Pharm.
58:331-337
2001
Dalteparin for enoxaparin interchange: Chart review shows promising clinical, economic outcomes
Formulary.
36:747-751
2000
Designing an electronic patient record with multiple real time decision support modules for managing diseases
Proc AMIA Symp.
1168
1999
Influencing physician prescribing.
Pharmacy practice management quarterly.
19(3):30-50
[PMID] 10747681.
1998
An assessment of osteoporosis risk factors: a computer-aided strategy to identify and evaluate patient risk factors using a clinic database
Third National Women's Health & Research.
201-205
1998
Preparing Pharmacists for Pharmaceutical Care
J Am Pharm Assoc.
38(6):644-645
1998
The Medication Attribution Scale: Perceived Effects of Antiretrovirals and Quality of Life
Quality of Life Research.
7:205-214
1997
. Therapeutic Outcomes Monitoring: Application of Pharmaceutical Care Guidelines to Community Pharmacy
JAPhA.
NS37(6):647-661
1997
Applying the Principles of Pharmaceutical Care to the Patient with Diabetes
In Wilson AL , Mehra IV. Managing the Patient with Diabetes.
Aspen Publishers:43-48
1997
Applying the principles of pharmaceutical care to the patient with diabetes.
Pharmacy practice management quarterly.
17(2):47-53
[PMID] 10168177.
1997
The Development and Evaluation of the Hypertension Temporal Orientation (HTO) Scale
Ethnicity & Disease.
7:41-54
1997
The Pharmacist’s Implementation of Pharmaceutical Care (PIPC) Model
Pharmaceutical Research.
135-144
1996
Behavioral pharmaceutical care scale for measuring pharmacists’ activities
American Journal of Health-System Pharmacists.
53:855-865
1996
Changing Pharmacists’ Practice Pattern: Pharmacists’ Implementation of Pharmaceutical Care Factors
Journal of Social and Administrative Pharmacy.
13(2):74-88
1996
Cost of acid peptic disorders in a managed-care organization.
Clinical therapeutics.
18(2):319-33; discussion 302
[PMID] 8733992.
1996
Economic, Clinical and Psychosocial Outcomes of Home Infusion Therapy: A Review of Published Studies
Continuing Education Series in Pharmacy & Managed Care.
3(5):8-12
1996
Ethnic Differences in Temporal Orientation and Its Implications for Hypertension Management
. Journal of Health and Social Behavior.
37(4):350-361
1996
Pharmacoeconomic evaluation of anesthesia in ambulatory surgery: comparison of desflurane to isoflurane and propofol.
Pharmacy practice management quarterly.
16(2):71-85
[PMID] 10172770.
1996
Providing Pharmaceutical Care in Community Practice: Differences between Providers and Non-Providers of Pharmaceutical Care
Journal of Social and Administrative Pharmacy.
12(1):8-12
1996
The Effects of Health and Treatment Perceptions on the Use of Prescribed Medication and Home Remedies among African American and White American Hypertensives
Social Science and Medicine.
43:906-917
1996
Therapeutic Outcomes Monitoring
Health Outcomes and Pharmaceutical Care. .
NY:Haworth Press:193-199
1996
Therapeutic Outcomes Monitoring: A Method for Implementing Pharmaceutical Care
Journal of Research in Pharmaceutical Economics.
8(1):193-198
1995
Cost of asthma illnesses: emergency department visits without admission.
Pharmacy practice management quarterly.
15(3):72-82
[PMID] 10151715.
1995
Cost/outcomes management in the hospital
Dialogues in Hospital Pharmacy.
1(3)
1995
Economic, Clinical and Psychosocial Outcomes of Home Infusion Therapy: A Review of Published Studies
Pharmacy Practice Management Quarterly.
15(1):57-77
1995
Evaluating the value, accuracy, and operational feasibility of DUE criteria.
Formulary (Cleveland, Ohio).
30(5):280-3
[PMID] 10151727.
1994
A pharmacoeconomic analysis of IV H2-receptor antagonist use in 40 hospitals.
Hospital formulary.
29(5):379-82, 388
[PMID] 10136601.
1994
Explaining patient satisfaction/dissatisfaction in high blood pressure prescription drug market: an application of equity theory and disconfirmation paradigm
Journal of Consumer Satisfaction, Dissatisfaction and Complaining Behavior.
7:53-73
1993
Risk for adverse events among patients receiving intravenous histamine2-receptor antagonists
Annals of Pharmacotherapy.
27(12):1532-1537
1993
The Vulnerable Consumer in the High Blood Pressure Drug Market: Bothered but Satisfied?
Advances in Consumer Research.
20:245-252
1993
Use of i.v. cimetidine, ranitidine, and famotidine in 40 hospitals.
American journal of hospital pharmacy.
50(10):2077-81
[PMID] 8238052.
1992
A framework for evaluating the work of pharmacists.
Topics in hospital pharmacy management.
12(1):9-19
[PMID] 10128703.
1991
Impact of a Clinical Pharmacist on Antibiotic Prescribing: A Multicenter Trial
Journal of Pharmacy Technology.
7:195-200
1991
Patient Satisfaction/Dissatisfaction and Post Exchange Actions in the High Blood Pressure Prescription Drug Market: A Preliminary Report.
Journal of Consumer Satisfaction, Dissatisfaction and Complaining Behavior.
4:84-92
1991
What are the fiscal implications of pharmaceutical biotechnology and its impact on the healthcare marketplace
FSHP Bulletin.
3(5)
1990
Selection of Pharmacy Providers and Other Primary Care Providers by Young Families
Journal of Pharmaceutical Marketing & Management.
4(3):41-59
1990
Therapeutic Risk Assessment Model for Identifying Patients with Adverse Drug Reactions
American Journal of Hospital Pharmacy.
47:330-334
1989
Needs Assessment and the Cardiac Rehabilitation Patient: A Focus on Medication Teaching
Journal of Pharmacy Technology.
5:57-62
1989
Confirmatory Factor Analysis of a Professionalism Scale in Pharmacy
Journal of Social and Administrative Pharmacy.
6(1):31-38
1989
Criteria for Staff Pharmacist Selection in Ohio
American Journal of Hospital Pharmacy.
46:295-301
1989
Factors Influencing Pharmacists’ Selection of Their First Practice Setting
American Journal of Hospital Pharmacy.
46:2294-2300
1989
How to Evaluate Progressive Pharmaceutical Services
Topics in Hospital Pharmacy Management.
9(2):73-74
1989
National Survey of Critical-Care Pharmaceutical Services
American Journal of Hospital Pharmacy.
46:2308-2312
1989
Pharmacist-selection methods used by pharmacy managers.
American journal of hospital pharmacy.
46(9):1824-6
[PMID] 2801719.
1989
Pharmacists’ Decision Making in the Selection of Generic Pharmaceuticals
Journal of Pharmaceutical Marketing & Management.
4(1):75-91
1989
Proceedings of a Symposium: The Impact of Cost Containment on Hospital Pharmacy Operations
Journal of Research in Pharmaceutical Economics.
1(2)
1988
Anatomy of Today’s Sales Training Programs
Medical Marketing and Media.
23(3):8-16
1988
Formulary Decision Making: Identifying Factors That Influence P&T Committee Drug Evaluations
Hospital Formulary.
23:174-178
1988
Impact of Medication Counseling by Pharmacists in the Veterans Administration Setting.
ASHP Foundation, Inc.
Washington D.C.:
1988
Opinions of Pharmacy, Medicine, and Pharmaceutical Industry Leaders about Hypothetical Therapeutic-Interchange Legislation
American Journal of Hospital Pharmacy.
45:570-577
1988
Prescribing Authority for Pharmacists as Viewed by Organized Pharmacy, Organized Medicine, and the Pharmaceutical Industry
Drug Intelligence and Clinical Pharmacy.
22:241-246
1988
Program Planning of a Biomedical Communications Center: An Implementation-Oriented Approach
Journal of Biocommunications.
Winter:2-8
1988
Sensitivity and Specificity of Three Methods of Detecting Adverse Drug Reactions
American Journal of Hospital Pharmacy.
45:1534-1539
1987
An Evaluation of Multi-Attribute Models for Physician Acceptance of Pharmacist-Initiated Drug Therapy Recommendations
Journal of Geriatric Drug Therapy.
1(3):49-64
1987
Development of a Data Base to Assist in the Dispensing Fee Determination for Participating Pharmacy Providers in the Ohio Medicaid Program
Ohio Pharmacist.
36(5):144-146
1987
Handling Antineoplastic Drug Admixtures at Cancer Centers: Practices and Pharmacist Attitudes
American Journal of Hospital Pharmacy.
44:1090-1095
1987
Implementation and Evaluation of a Flexitime Program Involving Pharmacy IV Admixture Technicians
Hospital Pharmacy.
1987(22):261-264
1987
Managed Health Care
Proceedings on The Changing Health Care Environment: It’s Impact on Pharmacy and the Pharmaceutical Industry.
77-80
1987
Pharmacist Rehabilitation Program: The Role of the Pharmacist as an Intervenor
Ohio Pharmacist.
36(3):81-83
1987
Pharmacist Rehabilitation Program: The Role of the Pharmacist as an Intervenor
OSHP Bulletin.
7(3)
1987
Pharmacist Rehabilitation: The National Experience and the Ohio Program
Ohio Pharmacist.
36(2):44-47
1987
Pharmacists’ Opinions about Compliance with Recommendations for Intravenous Admixture Practices
American Journal of Hospital Pharmacy.
1987(44):2077-2084
1987
Professional Attitudes of Ohio Pharmacists Working in Three Practice Settings
American Journal of Hospital Pharmacy.
44:795-799
1986
Cost Benefit and Cost Effectiveness Analysis: A Bibliography for Pharmacists
Hospital Pharmacy.
21:1072-1075
1986
Influencing Physician Acceptance of Consultant Pharmacists’ Recommendations
The Consultant Pharmacist.
1:129-133
1986
Pharmacists’ Beliefs and Values about Advertising Patient-Oriented Services
Journal of Health Care Marketing.
6(1):35-41
1985
Designing a Pharmacy Survey
Topics in Hospital Pharmacy Management.
5(1):37-45
1985
Drug Choice as a Problem-Solving Process
Medical Care.
23:967-976
1985
Predicting the Formulary Decision Making of Pharmacy and Therapeutics Committee Members
ASHP Research and Education Foundation.
1984
1984 Ohio Pharmacist Salary and Fringe Benefit Survey: Fringe Benefit Report of Full-Time Hospital Pharmacists
Ohio Pharmacist.
1984
1984 Ohio Pharmacist Salary and Fringe Benefit Survey: Salary Report of Full-Time Hospital Pharmacists
OSHP Bulletin.
4(3)
1984
1984 Pharmacist Report of Full-Time Hospital Pharmacists
Ohio Pharma.
1984
Ohio Pharmacist Salary and Fringe Benefit Survey: Fringe Benefit Report of Part-Time Hospital Pharmacists
Ohio Stae Hospital Bulletin.
4(4)
1984
Professional Pharmacy Services – Which Ones to Advertise
. NARD Journal.
Sept:141-142
1983
Motivating Pharmacy Personnel: A Managerial Framework
Topics in Hospital Pharmacy Management.
3:1891-1897
1982
Prescribers’ Beliefs and Values as Predictors of Drug Choices
American Journal of Hospital Pharmacy.
39:1891-1897
1981
How Physicians Choose the Drugs They Prescribe
. Topics in Hospital Pharmacy Management.
1:23-44
1981
Why Worry About Job Satisfaction
American Journal of Hospital Pharmacy.
38
1979
Another Day, Another Dollar – A Primer on Motivation: It Seems Like Nobody Wants to Really Work Anymore
Pharmacy Management.
151:214-218
1978
Therapeutic Update
Iowa Pharmacist.
33(2)
Hospital Pharmacy Management: Forms, Checklists and Guidelines
Gaithersburg, MD.: Aspen.
Grants
Feb 2023
– Jun 2023
Collaborative Practice Agreement Medication Therapy Management Promotional Campaign SOW22-509
Role: Principal Investigator
Funding: FL DEPT OF HLTH
Mar 2022
ACTIVE
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
Role: Co-Investigator
Funding: NATL INST OF HLTH NINR
Jan 2021
– Mar 2022
CDK 4/6 inhibitors use among metastatic breast cancer patients: Early discontinuation and management of adverse events
Role: Principal Investigator
Funding: PFIZER INC
Sep 2020
– Jun 2021
The 6th Biennial Science of Global Prostate Cancer Disparities in Black Men of African Ancestry
Role: Other
Funding: NATL INST OF HLTH NCI
May 2019
– Jun 2023
Community Health workers practice improvements – FY1819
Role: Principal Investigator
Funding: FL DEPT OF HLTH
via CTRS FOR DISEASE CONTROL AND PREVENTION
Jun 2018
– Jun 2019
Identifying Medication Use Problems and Improving Minority Health through Community Health Workers
Role: Other
Funding: AMER FOU FOR PHARM EDU
Jan 2018
– Jun 2018
Diabetes Self-Management Education Via Telehealth Feasibility Study SOW16-042
Role: Principal Investigator
Funding: FL DEPT OF HLTH
Dec 2017
– Nov 2018
Summer Health Professions Education Program
Role: Project Manager
Funding: ROBERT WOOD JOHNSON FOUNDATION
Jul 2017
– Sep 2018
Medication Therapy Management Support Training Servcies
Role: Principal Investigator
Funding: FL DEPT OF HLTH
via CTRS FOR DISEASE CONTROL AND PREVENTION
Sep 2016
– Aug 2017
SCIENCE OF GLOBAL PROSTATE CANCER DISPARITIES
Role: Co-Investigator
Funding: NATL INST OF HLTH NCI
Sep 2016
– Jun 2017
Community Health workers practice improvements – FY1617
Role: Principal Investigator
Funding: FL DEPT OF HLTH
Sep 2014
– Aug 2019
Florida Minority Cancer Research and Training Center: Feasibility Studies
Role: Co-Investigator
Funding: NATL INST OF HLTH NCI
Education
Ph.D.
1983
·
Virginia Commonwealth University‐Medical College of Virginia
M.Sc.
1981
·
University of Iowa
ASHP Accredited Residency in Hospital Pharmacy
1976-1977
·
Mayo Clinic, Rochester
B.S.
1976
·
University of Connecticut
Contact Details
Phones:
- Business:
- (352) 273-6265
Emails:
- Business:
- segal@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100496
GAINESVILLE FL 32610 - Business Street:
-
1225 CENTER DR.
HPNP 3334
GAINESVILLE FL 32610